Therefore, we included all published studies retrieved from the literature to perform an updated comprehensive meta‐analysis to assess the associations between the ALDH2 and ADH1B polymorphisms and the ESCC risk. This evidence concerns the gene ALDH2 and esophageal squamous cell carcinoma.